Pipeline Pulse: Charles River Labs Battle Card

🚀 Battle Card: Charles River Laboratories International, Inc.

• Dr. Namandjé N. Bumpus, Chair, Scientific Advisory Board · 🔗 LinkedIn

• Industry is shifting toward New Approach Methodologies to reduce animal testing and accelerate drug development → Source (This Charles River Laboratories International, Inc. sales trigger flags a major pivot in R&D priorities.)

• Legacy animal testing models slowing throughput

• Regulatory uncertainty around NAMs validation

• Primary: Regulatory Validation Platform → Accelerate NAMs approvals

• Expansion: Data Integration & Analytics Suite → Streamline NAM workflows and reduce costs

• HQ: Wilmington, MA

• Employees: ≈ 18,000

• Rev: ≈ $3.5 B

• Website: criver.com

🤼 Competitive Intel

• Certara — in silico modeling
• Unique edge: End-to-end PK/PD and QSP simulations
• Evaluated by VP R&D & Head of Translational Science

• Toxys — alternative toxicity testing
• Unique edge: Specialized developmental & reproductive toxicity NAMs
• Evaluated by Dir. Safety Assessment & Regulatory Affairs

• Epithelix — organ-on-chip
• Unique edge: Ready-to-use human tissue models (respiratory, GI)
• Evaluated by Head of Lab Ops & CTO

• Genedata — data analytics platform
• Unique edge: Integrated multi-omics data management
• Evaluated by CIO & VP of Technology

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑≈ TBD❑
OFFER_BRIEF   = ❑≈ TBD❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Namandjé
COMPANY     = Charles River Laboratories International, Inc.
DEPT        = Scientific Advisory Board
SIZE        = ≈ TBD
BOTTLENECK  = Legacy animal testing models slowing throughput
EVENT       = Scientific Advisory Board launch
DETAIL      = Alternative Method Innovation and Adoption
PAIN        = Legacy animal testing models slowing throughput
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251015276655&div=41152219
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 18,000
REV_EST     = ≈ $3.5 B

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ TBD-person Scientific Advisory Board

Namandjé—noticed your Scientific Advisory Board team is ≈ TBD.

That’s when Legacy animal testing models slowing throughput slows growth.

We helped ≈ TBD fix this with ≈ TBD.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ TBD.

DM ≤45 words, TONE:
Saw your post about Alternative Method Innovation and Adoption — Legacy animal testing models slowing throughput.  
≈ TBD. ≈ TBD.  
Quick chat?